STAT (@statnews) header
STAT (@statnews) profile picture

STAT

@statnews

Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://nitter.cf/t.co/CBx3GZBv31

statnews.com/
Joined July 2015
  • Tweets89.6K
  • Following4.7K
  • Followers165K
18KMedia
Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)Photo by STAT (@statnews)
Pinned Tweet
STAT (@statnews) profile picture
STAT
@statnewsOct 7
This year, as in past years, we’ve found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the biggest questions in science and medicine. Meet the 2026 #STATWunderkinds! statnews.com/wunderkinds/

Meet the 2026 STAT Wunderkinds

This year, as in past years, we've found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the

statnews.com
4
6
2
21
10,188
Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry. More drastic measures, like ‘Medicare for All,’ are gaining support statnews.com/2026/10/29/heal…
Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry

Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry

As costs surge, voters are embracing more radical solutions to the crisis.

statnews.com
1
836
A judge ruled that federal regulators exceeded their authority in narrowing the exceptions to Medicaid work requirements for people with medical issues. trib.al/zbbsMPM
Federal judge rejects new Medicaid ‘frailty’ definition for work requirements

Federal judge rejects new Medicaid ‘frailty’ definition for work requirements

A judge ruled that federal regulators exceeded their authority in narrowing the exceptions to Medicaid work requirements for people with medical issues.

statnews.com
1
1
2
1,064
The way Epic Systems, the dominant U.S. electronic health records vendor, behaves in the market ends up undercutting innovations. STAT's Casey Ross explains:
4
1
2
1,263
Read STAT's latest Epic coverage: statnews.com/2026/10/28/epic…
As Epic’s dominance grows, its iron grip is choking innovation in health technology

As Epic’s dominance grows, its iron grip is choking innovation in health technology

A STAT investigation found that Epic selectively withholds access to patient data, disadvantaging rival software developers and stymying innovation.

statnews.com
1
1
2
801
STAT retweeted
Rick Berke (@rickberke) profile picture
Rick Berke
@rickberke3h
Helen Branswell was the most prescient reporter on Covid, and a wonderful colleague and friend. This video she recorded in late summer is an inspiration to us all.
STAT (@statnews) profile pictureSTAT
@statnews3h
Last night, STAT's Executive Editor Rick Berke accepted, in memory of Helen Branswell, the Kovler Prize for Trust in Life Science Journalism. Watch this video that Helen recorded in late summer to accept the award. We miss you, Helen. youtube.com/watch?v=Rsu5Zr8I…
Veteran Medical Reporter Helen Branswell Reflects on Career

Veteran Medical Reporter Helen Branswell Reflects on Career

The Foundation for the National Institutes of Health (FNIH) named H...

youtube.com
4
18
1,375
Last night, STAT's Executive Editor Rick Berke accepted, in memory of Helen Branswell, the Kovler Prize for Trust in Life Science Journalism. Watch this video that Helen recorded in late summer to accept the award. We miss you, Helen. youtube.com/watch?v=Rsu5Zr8I…
Veteran Medical Reporter Helen Branswell Reflects on Career

Veteran Medical Reporter Helen Branswell Reflects on Career

The Foundation for the National Institutes of Health (FNIH) named H...

youtube.com
1
5
2
12
3,835
After two deaths in autoimmune cell therapy trial, Artiva is shutting down trib.al/6IHOl57
After two deaths in autoimmune cell therapy trial, Artiva is shutting down

After two deaths in autoimmune cell therapy trial, Artiva is shutting down

Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.

statnews.com
1
1
1,188
This week's Biotech Scorecard newsletter: -- Vertex $VRTX kidney disease drug scrutinized for infection risk $VERA $OTSKY -- 10 FDA drug approval decisions on tap before 2026 ends. statnews.com/2026/10/29/biot…
Vertex kidney disease drug scrutinized for infection risk

Vertex kidney disease drug scrutinized for infection risk

Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.

statnews.com
16
5,952
#Breaking: A Trump administration rule will force pharmacy benefit managers to disclose fees and compensation details currently kept private. trib.al/GQ87hJh
New federal rule will require prescription drug middlemen to share secret payments data

New federal rule will require prescription drug middlemen to share secret payments data

A Trump administration rule will force pharmacy benefit managers to disclose fees and compensation details currently kept private.

statnews.com
1
1
1,341
In this edition of STAT Health Tech: An Epic investigation, a Teladoc surprise, and figuring out how to pay for AI. trib.al/nsITIlw
The EPIC investigation, and a Teladoc surprise

The EPIC investigation, and a Teladoc surprise

In this edition of STAT Health Tech: An Epic investigation, a Teladoc surprise, and figuring out how to pay for AI.

statnews.com
1
1,175
RFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement. trib.al/joIYC8g
Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA

Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA

RFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.

statnews.com
1,226
Two reporters did what has eluded so many others: penetrating the behemoth that is Epic
Bob Herman (@bobjherman) profile pictureBob Herman@bobjhermanOct 28
“It’s very clear Epic owns the market. Its prices are extraordinary. It has killed innovators left and right — it’s time for a change.” A must-read story from Casey Ross and @brittanytrang, who are investigating the electronic health records giant Epic. statnews.com/2026/10/28/epic…
As Epic’s dominance grows, its iron grip is choking innovation in health technology

As Epic’s dominance grows, its iron grip is choking innovation in health technology

A STAT investigation found that Epic selectively withholds access to patient data, disadvantaging rival software developers and stymying innovation.

statnews.com
14
149
34,538
New atlas of colorectal tumors sheds light on why cancers in young people are more dangerous. The database includes 189 tumors from patients ranging from their 20s to their 90s. statnews.com/2026/10/29/earl…
New atlas of colorectal tumors sheds light on why cancers in young people are more dangerous

New atlas of colorectal tumors sheds light on why cancers in young people are more dangerous

A new atlas of colorectal tumors sheds light on why cancers in young people are more dangerous.

statnews.com
1
2
1,238
Martin Kulldorff, the biostatistician who advocated against Covid lockdowns, insisted that the rise in measles cases is caused by a widely disputed claim about said lockdowns: trib.al/Jxio0Xr
Martin Kulldorff critiques scientific gatekeepers at NIH lecture

Martin Kulldorff critiques scientific gatekeepers at NIH lecture

Martin Kulldorff, the biostatistician who advocated against Covid lockdowns, insisted that the rise in measles cases is caused by a widely disputed claim about said lockdowns:

statnews.com
1
1,376
Ahead of a crucial election, RFK Jr. is attempting to rally his MAHA base statnews.com/2026/10/29/rfk-…
Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA

Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA

RFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.

statnews.com
1,291
As health care costs strain small businesses and workers, American voters are calling for reform. Part 6 of STAT's series 'Out of Pocket, Out of Reach.' statnews.com/2026/10/29/heal…
Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry

Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry

As costs surge, voters are embracing more radical solutions to the crisis.

statnews.com
3
1,217
RFK Jr. is making his closing argument to Americans ahead of the midterms election: Vote Republican and we'll Make America Healthy Again, stick with changing vaccine policy, and crack down on fraud (which, in turn, will lower costs, he says). My latest: statnews.com/2026/10/29/rfk-…
Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA

Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA

RFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.

statnews.com
4
1
6
1,969
Abdul El-Sayed, the Democratic Senate candidate in Michigan, pushes back against the RFK Jr.'s claims, and the new FDA policy around peptides. trib.al/SRFOR8j
El-Sayed claps back at RFK Jr., and FDA's ‘enforcement discretion’ on peptides

El-Sayed claps back at RFK Jr., and FDA's ‘enforcement discretion’ on peptides

Abdul El-Sayed, the Democratic Senate candidate in Michigan, pushes back against the RFK Jr.'s claims, and the new FDA policy around peptides.

statnews.com
1,111
Great news for peptide fans: The Trump administration is giving the peptide craze a regulatory boost, despite objections from FDA career scientists. trib.al/bzY5qh8
HHS green lights six peptides, despite concerns from FDA scientists

HHS green lights six peptides, despite concerns from FDA scientists

Great news for peptide fans: The Trump administration is giving the peptide craze a regulatory boost, despite objections from FDA career scientists.

statnews.com
1
1
1,459
Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk. trib.al/jAXo8eg
Vertex kidney disease drug scrutinized for infection risk

Vertex kidney disease drug scrutinized for infection risk

Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.

statnews.com
1
1,617
Load more